Portfolio company
Latent Labs
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
The company develops generative artificial intelligence models to design and optimise proteins for biotechnology and pharmaceutical firms.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Profluent
This company develops generative artificial intelligence models to design novel proteins and gene editors for pharmaceutical, biotechnology and agricultural organisations.
310.ai
This company develops generative artificial intelligence models to design novel proteins and biomolecules for pharmaceutical and biotechnology organisations.
Diffuse Bio
This company develops generative artificial intelligence software and experimental screening platforms for protein design and validation for pharmaceutical and biotechnology researchers.
Open Protein
This company provides a no-code machine learning platform for protein engineering and sequence generation to researchers in biotechnology, pharmaceuticals and academia.
expressionedits
This company develops a computational platform using artificial intelligence to optimise gene design and enhance protein production for biotechnology and pharmaceutical organisations.
Profluent Bio
Profluent Bio develops generative artificial intelligence models to design novel functional proteins for biopharmaceutical companies and industrial partners.
Ionlace
This company develops an artificial intelligence platform for designing and producing novel proteins for the biotechnology and pharmaceutical industries.
Provolut
This company develops artificial intelligence software for protein and enzyme engineering to support researchers in the pharmaceutical and industrial biotechnology sectors.
